Danske Bank’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-600
Closed -$63.7K 1291
2025
Q4
$63.7K Hold
600
﹤0.01% 907
2025
Q3
$76.2K Sell
600
-84
-12% -$10K ﹤0.01% 918
2025
Q2
$83.9K Sell
684
-22,723
-97% -$2.6M ﹤0.01% 896
2025
Q1
$2.37M Buy
23,407
+23,207
+11,604% +$2.27M 0.01% 618
2024
Q4
$18.5K Sell
200
-900
-82% -$88.4K ﹤0.01% 1014
2024
Q3
$106K Sell
1,100
-17,478
-94% -$1.57M ﹤0.01% 1005
2024
Q2
$1.59M Sell
18,578
-5,815
-24% -$488K 0.01% 660
2024
Q1
$2.01M Buy
+24,393
New +$1.79M 0.01% 685

Other funds holding EHC

Danske Bank's EHC Position: Q1 2026 in Review

Danske Bank sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 600 shares — an estimated $63.7K sold.

Danske Bank first reported a position in EHC in Q1 2024 and held it in 8 quarters. The position peaked at $2.37M in Q1 2025. 579 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Danske Bank reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 600 Encompass Health shares in Q1 2026, an estimated $63.7K.
  • Danske Bank first reported a position in Encompass Health in Q1 2024 and held it in 8 quarters.
  • Danske Bank's Encompass Health position peaked at $2.37M in Q1 2025.
  • 579 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.